Morphosys says Novartis takeover progressing as planned for H1 2024

Morphosys AG

29/04/2024 09:54

BERLIN, April 29 (Reuters) - Morphosys  MORG.DE  said
its takeover by Novartis  NOVN.S  was still expected to be
closed in the first half of this year, in a statement responding
to a possible safety risk reported by specialist news website
STAT News that knocked the company's share price on Monday.
    "The planned acquisition by Novartis is progressing
steadily," a Morphosys spokesperson said in an emailed response
to Reuters. "We remain confident in the benefit-risk profile of
the combination of pelabresib and ruxolitinib."
    

 (Reporting by Patricia Weiss, Writing by Rachel More, Editing
by Andrey Sychev)
 ((rachel.more@thomsonreuters.com;))